Back

Minor Consent state policies and COVID-19 vaccination in adolescents

Litchy, C.; Semprini, J.

2026-04-11 public and global health
10.64898/2026.04.10.26350608 medRxiv
Show abstract

Background Ever since the COVID-19 vaccine became available, vaccinations in adolescents lagged behind adults. Whether adolescent vaccination rates were higher in states with "Minor Consent" policies remains unknown. Methods We accessed adolescent (aged 12-17) county-level vaccine administration data from the CDC (12/2020-05/2023). Our outcomes were COVID-19 vaccination counts for: 1) initial dose, 2) completed series doses, and 3) booster doses. Panel Poisson regression models with state and time random effects, seasonal fixed effects, log-population offsets, and adult vaccination rates were estimated to calculate incidence rate ratios (IRR), testing the association between residing in a state with a Minor Consent policy and COVID-19 vaccine uptake. Results Overall, for the initial dose and complete series, there was no difference in adolescent COVID-19 vaccination between states with or without Minor Consent policies. However, we found that Minor Consent policies were associated with lower COVID-19 booster doses (IRR = 0.582; 95% CI: 0.409, 0.828; p = 0.0026). This association was not found in urban counties (IRR = 0.867; CI = 0.722, 1.043; p = 0.1295), but only in rural counties (IRR = 0.541; CI = 0.401, 0.730; p < 0.0001). Conclusions Minor Consent policies were not associated with higher adolescent COVID-19 vaccination. Rather, we found that Minor Consent policies were associated with lower adolescent vaccination for booster doses in rural counties. Despite minimal evidence of impact, states continue to implement Minor Consent vaccination policies. Future research should investigate not just other vaccines, but also how Minor Consent policies impact parental trust in public health more broadly.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Vaccine
189 papers in training set
Top 0.1%
25.7%
2
Vaccines
196 papers in training set
Top 0.1%
12.3%
3
BMC Public Health
147 papers in training set
Top 0.7%
6.3%
4
JAMA Network Open
127 papers in training set
Top 0.6%
4.8%
5
PLOS Medicine
98 papers in training set
Top 1%
3.6%
50% of probability mass above
6
PLOS ONE
4510 papers in training set
Top 40%
3.6%
7
Preventive Medicine Reports
14 papers in training set
Top 0.1%
3.6%
8
Vaccine: X
19 papers in training set
Top 0.1%
3.1%
9
Human Vaccines & Immunotherapeutics
25 papers in training set
Top 0.3%
2.1%
10
BMC Medicine
163 papers in training set
Top 3%
1.9%
11
JMIR Public Health and Surveillance
45 papers in training set
Top 2%
1.7%
12
American Journal of Epidemiology
57 papers in training set
Top 0.7%
1.7%
13
BMJ Open
554 papers in training set
Top 10%
1.5%
14
PLOS Global Public Health
293 papers in training set
Top 4%
1.3%
15
Eurosurveillance
80 papers in training set
Top 1%
1.2%
16
The Lancet Regional Health - Americas
22 papers in training set
Top 0.1%
1.2%
17
American Journal of Preventive Medicine
11 papers in training set
Top 0.3%
1.2%
18
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.2%
19
Journal of Epidemiology and Community Health
32 papers in training set
Top 0.5%
0.9%
20
BMC Infectious Diseases
118 papers in training set
Top 5%
0.9%
21
Frontiers in Public Health
140 papers in training set
Top 8%
0.8%
22
The Lancet Public Health
20 papers in training set
Top 0.7%
0.7%
23
International Journal of Environmental Research and Public Health
124 papers in training set
Top 7%
0.7%
24
The Lancet Regional Health - Europe
32 papers in training set
Top 0.5%
0.6%
25
International Journal of Public Health
17 papers in training set
Top 0.5%
0.6%
26
Annals of Internal Medicine
27 papers in training set
Top 1%
0.6%